U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07690163) titled 'DIabetes GLycemic Assessment in Newly Confirmed Episodes' on July 01.
Brief Summary: This is a prospective, open-label, randomized controlled trial involving 80 adult patients with newly diagnosed T2DM (diagnosed within the last 3 months) recruited at the Bogomolets National Medical University. Participants may be lifestyle-controlled or receiving stable non-insulin anti-diabetic medications. Participants will be randomized in a 1:1 ratio to either the Real-Time Continuous Glucose Monitoring group (CGM group) or the control group (standard Self-Monitoring of Blood Glucose [SMBG] using conventional glucometers).
The gathered data wil...